Specifically, BATF2 dimerization with activator protein 1 (AP-1) subunits has been shown to suppress cell proliferation across several cancer types, and reduced expression or abnormal cellular localization of BATF2 contributed to increased tumor growth and the expression of cell cycle progression genes (15, 36, 37, 38). This evidence concerns the gene BATF2 and cancer.